ALBENDAZOLE
Substance profile for UNII F4216019LN, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#
- UNII
- F4216019LN
- Preferred term
- ALBENDAZOLE
- Registry number
- 54965-21-8
- EC number
- 259-414-7
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C12H15N3O2S

Chemical And Database Identifiers#
- InChIKey
- HXHWSAZORRCQMX-UHFFFAOYSA-N
- SMILES
- CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2
- RxCUI
- 430
- PubChem
- 2082
- NCIt
- C47384
- INN ID
- 3967
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem Compound | 2082 | |
| PubChem InChIKey Search | HXHWSAZORRCQMX-UHFFFAOYSA-N | |
| RxNorm | 430 | |
| NCI Thesaurus | C47384 | |
| FDA Substance Registration System | F4216019LN | |
| European Community number | 259-414-7 |
DailyMed Socrata Ingredients#
| Type | DailyMed label | SPL version |
|---|---|---|
| ACTIVE INGREDIENT | ALBENZA (ALBENDAZOLE) TABLET, FILM COATED ALBENZA (ALBENDAZOLE) TABLET, CHEWABLE [AMEDRA PHARMACEUTICALS LLC] | 8 |
| ACTIVE MOIETY | ALBENZA (ALBENDAZOLE) TABLET, FILM COATED ALBENZA (ALBENDAZOLE) TABLET, CHEWABLE [AMEDRA PHARMACEUTICALS LLC] | 8 |
| ACTIVE MOIETY | VALBAZEN (ALBENDAZOLE) SUSPENSION [ZOETIS INC.] | 2 |
| ACTIVE INGREDIENT | VALBAZEN (ALBENDAZOLE) SUSPENSION [ZOETIS INC.] | 2 |
| ACTIVE MOIETY | ALBENZA (ALBENDAZOLE) TABLET, FILM COATED [RXPAK DIVISION OF MCKESSON CORPORATION] | 1 |
| ACTIVE INGREDIENT | ALBENZA (ALBENDAZOLE) TABLET, FILM COATED [RXPAK DIVISION OF MCKESSON CORPORATION] | 1 |
| ACTIVE INGREDIENT | X (ALBENDAZOLE) POWDER [AX PHARMACEUTICAL CORP] | 1 |
| ACTIVE MOIETY | X (ALBENDAZOLE) POWDER [AX PHARMACEUTICAL CORP] | 1 |